Literature DB >> 21102345

Comparison of biexponential and monoexponential model of diffusion weighted imaging in evaluation of renal lesions: preliminary experience.

Hersh Chandarana1, Vivian S Lee, Elizabeth Hecht, Bachir Taouli, Eric E Sigmund.   

Abstract

OBJECTIVES: To obtain intravoxel incoherent motion (IVIM) parameters with biexponential analysis of multiple b-value diffusion-weighted imaging (DWI) and compare these parameters to apparent diffusion coefficient (ADC) obtained with monoexponential modeling in their ability to discriminate enhancing from nonenhancing renal lesions.
MATERIALS AND METHODS: Twenty-eight patients were imaged at 1.5 T utilizing contrast-enhanced (CE) magnetic resonance imaging (MRI) and breath-hold DWI using 8 b values (range: 0-800 s/mm(2)). Perfusion fraction (f(p)), tissue diffusivity (D(t)), and pseudo-diffusion coefficient (D(p)) were calculated using segmented biexponential analysis. ADC(total) and ADC(0-400-800) were calculated with monoexponential fitting of the DWI data. f(p), D(t), D(p), ADC(total), and ADC(0-400-800) were compared between enhancing and nonenhancing renal lesions. Receiver operating characteristic analysis was performed for all DWI parameters. f(p) was correlated with percent enhancement.
RESULTS: There were a total of 31 renal lesions (15 enhancing and 16 nonenhancing) in 28 patients on CE-MRI. f(p) of enhancing masses was significantly higher (27.9 vs. 6.1) and D(t) was significantly lower (1.47 vs. 2.40 ×10(-3) mm(2)/s). IVIM parameters f(p) and D(t) demonstrated higher accuracy in differentiating enhancing from nonenhancing renal lesions compared with monoexponential parameters ADC(0-400-800) and ADC(total), with area under the curve of 0.946, 0.896, 0.854, and 0.675, respectively. There was a good correlation between f(p) and percent enhancement (r = 0.7; P < 0.001).
CONCLUSION: IVIM parameters f(p) and D(t) obtained with biexponential fitting of multi-b value DWI have higher accuracy compared with ADC (obtained with monoexponential fit) in discriminating enhancing from nonenhancing renal lesions. Furthermore, f(p) demonstrates good correlation with percent enhancement and can provide information regarding lesion vascularity without the use of exogenous contrast agent.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21102345     DOI: 10.1097/RLI.0b013e3181ffc485

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  63 in total

1.  Interstitial fluid pressure correlates with intravoxel incoherent motion imaging metrics in a mouse mammary carcinoma model.

Authors:  Sungheon Kim; Lindsey Decarlo; Gene Y Cho; Jens H Jensen; Daniel K Sodickson; Linda Moy; Silvia Formenti; Robert J Schneider; Judith D Goldberg; Eric E Sigmund
Journal:  NMR Biomed       Date:  2011-11-09       Impact factor: 4.044

2.  Using intravoxel incoherent motion MR imaging to study the renal pathophysiological process of contrast-induced acute kidney injury in rats: Comparison with conventional DWI and arterial spin labelling.

Authors:  Long Liang; Wen-Bo Chen; Kannie W Y Chan; Yu-Guo Li; Bin Zhang; Chang-Hong Liang; Guan-Shu Liu; Shui-Xing Zhang
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

3.  Increased signal intensity of prostate lesions on high b-value diffusion-weighted images as a predictive sign of malignancy.

Authors:  Michael Quentin; Lars Schimmöller; Christian Arsov; Robert Rabenalt; Gerald Antoch; Peter Albers; Dirk Blondin
Journal:  Eur Radiol       Date:  2013-08-31       Impact factor: 5.315

4.  Intravoxel incoherent motion diffusion-weighted imaging of hepatocellular carcinoma: Is there a correlation with flow and perfusion metrics obtained with dynamic contrast-enhanced MRI?

Authors:  Stefanie J Hectors; Mathilde Wagner; Cecilia Besa; Octavia Bane; Hadrien A Dyvorne; M Isabel Fiel; Hongfa Zhu; Michael Donovan; Bachir Taouli
Journal:  J Magn Reson Imaging       Date:  2016-02-26       Impact factor: 4.813

5.  Intravoxel incoherent motion diffusion-weighted imaging of resectable oesophageal squamous cell carcinoma: association with tumour stage.

Authors:  Yu-Cheng Huang; Tian-Wu Chen; Xiao-Ming Zhang; Nan-Lin Zeng; Rui Li; Yu-Lian Tang; Fan Chen; Yan-Li Chen
Journal:  Br J Radiol       Date:  2018-02-05       Impact factor: 3.039

6.  Relationship of renal apparent diffusion coefficient and functional MR urography in children with pelvicalyceal dilation.

Authors:  Maria A Bedoya; Jeffrey I Berman; Jorge Delgado; Dmitry Khrichenko; Christian A Barrera; Robert H Carson; Kassa Darge
Journal:  Pediatr Radiol       Date:  2019-04-19

7.  Pre-TACE kurtosis of ADCtotal derived from histogram analysis for diffusion-weighted imaging is the best independent predictor of prognosis in hepatocellular carcinoma.

Authors:  Li-Fang Wu; Sheng-Xiang Rao; Peng-Ju Xu; Li Yang; Cai-Zhong Chen; Hao Liu; Jian-Feng Huang; Cai-Xia Fu; Alice Halim; Meng-Su Zeng
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

8.  Renal Adiposity Confounds Quantitative Assessment of Markers of Renal Diffusion With MRI: A Proposed Correction Method.

Authors:  Behzad Ebrahimi; Ahmed Saad; Kai Jiang; Christopher M Ferguson; Hui Tang; John R Woollard; James F Glockner; Stephen C Textor; Lilach O Lerman
Journal:  Invest Radiol       Date:  2017-11       Impact factor: 6.016

9.  Diffusion analysis with triexponential function in hepatic steatosis.

Authors:  Tatsuya Hayashi; Tosiaki Miyati; Junji Takahashi; Yoshinori Tsuji; Hidesato Suzuki; Naomi Tagaya; Mariko Hiramoto; Kei Fukuzawa; Masakatsu Tano; Satoshi Saitoh
Journal:  Radiol Phys Technol       Date:  2013-10-04

10.  Non-Gaussian diffusion MR imaging of glioma: comparisons of multiple diffusion parameters and correlation with histologic grade and MIB-1 (Ki-67 labeling) index.

Authors:  Ren Yan; Pang Haopeng; Feng Xiaoyuan; Wu Jinsong; Zhang Jiawen; Yao Chengjun; Qiu Tianming; Xiong Ji; Sheng Mao; Ding Yueyue; Zhang Yong; Luo Jianfeng; Yao Zhenwei
Journal:  Neuroradiology       Date:  2015-10-22       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.